Feedback / Questions
Fovista (pegpleranib) - Iveric bio, Novartis, Roche
Novartis: Q4 & FY 2015 Results
(Novartis)
-
Jan 29, 2016 -
Anticipated regulatory filing for neovascular AMD in 2017
Anticipated regulatory
•
Ophthalmology
https://www.novartis.com/sites/novartisemea.prod.acquia-sites.com/files/q4-2015-ir-presentation.pdf
Jan 29, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.